Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3328543 | 0.91 | MAPT (0.79) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL4163474 | 0.91 | MAPT (0.79) | MEN1KMT2AMAPTALDH1A1LMNA | |
| Phosphonic Acid SCHEMBL11661426 | 0.91 | MEN1 (0.58) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL8934655 | 0.89 | MAPT (0.76) | MEN1KMT2AMAPTALDH1A1LMNA | |
| Fluoride SCHEMBL29135589 | 0.89 | MAPT (0.76) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL8934649 | 0.89 | MAPT (0.76) | MEN1KMT2AMAPTALDH1A1LMNA | |
| Diphenylsulfane SCHEMBL27732156 | 0.88 | MEN1 (0.55) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL8729226 | 0.87 | ALDH1A1 (0.62) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL11657737 | 0.85 | AGTR1 (0.58) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL2818369 | 0.84 | MAPT (0.70) | MEN1KMT2AMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058570-A | Application of metal ion doped graphene oxide film catalytic material in catalyzing thioether oxidation reaction to synthesize sulfone | 中国科学院理化技术研究所 | 2025-05-30 | — | — | CN | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-4511729-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-04-16 | — | — | US | claimed |
| US-4502998-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-03-05 | — | — | US | claimed |
| CN-120058570-A | Application of metal ion doped graphene oxide film catalytic material in catalyzing thioether oxidation reaction to synthesize sulfone | 中国科学院理化技术研究所 | 2025-05-30 | — | — | CN | disclosed |
| CN-119528762-A | Oxime oxalate compound, photoresist and application thereof | 北京云基科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-11500247-B2 | Liquid crystal sensor | PLATYPUS TECHNOLOGIES, LLC (US) | 2022-11-15 | — | — | US | disclosed |
| US-20210403456-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-12-30 | — | — | US | disclosed |
| US-20200409221-A1 | LIQUID CRYSTAL SENSOR | PLATYPUS TECHNOLOGIES, LLC | 2020-12-31 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-4511729-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-04-16 | — | — | US | disclosed |
| US-4511729-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-04-16 | — | — | US | disclosed |
| US-4502998-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |
| US-4502998-A | Nucleophilic substitution process | ETHYL CORPORATION (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0102476-A1 | Method of modulating the immune response system in mammals | AMERICAN CYANAMID COMPANY (US) | 1984-03-14 | — | — | EP | disclosed |
| US-4277398-A | ORANGE-COLORED, COUNTERACTING UNWANTED ABSORPTION OF MAGENTA DYES IN COLOR PHOTOGRAPHY | CIBA-GEIGY AG (CH) | 1981-07-07 | — | — | US | disclosed |
| US-3988467-A | Aminoacyl compounds | CIBA-GEIGY CORPORATION (US) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403456-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY | SLC6A11, SCN1A, SCN1B | MEN1 450/4885KMT2A 279/4885MAPT 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.